Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The International Organization for Standardization (ISO) late last month released its long-awaited revision to ISO 13485, the global standard for medical device quality management systems (QMS), which replaces the previous version from 2003.
The new revision places a greater emphasis on QMS throughout the supply chain and product lifecycle, as well as device usability and postmarket surveillance requirements.
Over the next three years, ISO 13485:2003 and ISO 13485:2016 will coexist, allowing manufacturers, accreditation/certification bodies and regulators time to transition to the new standard.
According to a draft transition planning guidance, organizations will still be able to be accredited for either ISO 13485:2003 or ISO 13485:2016 for the first two years of the transition period; however, after the second year, new accreditation will only be given for ISO 13485:2016.
After the third year, the guidance says, "any existing certification issued to ISO 13485:2003 will not be valid."
Many organizations involved with medical device development, including manufacturers and service providers use ISO 13485 to "demonstrate [their] ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements."
Regulators worldwide have integrated ISO 13485 into their regulatory systems, including those in the US, EU, Canada, Australia and Japan. The standard is sometimes adapted to meet local requirements, for example, EN ISO 13485:2012 in the EU adds a forward and several annexes to the standard specific to the region.
ISO 13485 is also used for the Medical Device Single Audit Program (MDSAP), an international effort to reduce redundant audits of medical device manufacturers.
"Many jurisdictions have got quality management system requirements for medical device manufacture and supply, so it's really important that there's a common understanding between the regulator and the industry as to what's required for that quality management system," said Eamonn Hoxey, former chair of ISO's technical committee for quality management and corresponding general aspects for medical devices in a video interview on ISO's website.
The decision to revise ISO 13485 was made following the most recent review of the 2003 standard, according to Hoxey.
"When we did the last review, we had discussions with the regulatory authorities and we – both industry and the authorities – felt that it was time to revise the standard … Since 2003, a number of jurisdictions have either revised or introduced regulations for medical devices, so we want to make sure the quality management system requirements align fully with those regulatory requirements."
When asked about the new revision, ISO representative Maria Lazarte, relayed a list of major changes from the technical committee for ISO 13485.
Some of the biggest changes between the 2003 and 2016 version include:
Speaking to those changes, Hoxey said "it's important to bear in mind that ISO 13485 does deal with the whole lifecycle from design and development, through manufacture, transport … and on to the end of life."
Tags: ISO 13485, ISO 13485:2003, ISO 13485:2016, Quality Management Systems, QMS